Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Curocell Inc.

Clinical trials sponsored by Curocell Inc., explained in plain language.

Curocell Inc. 372320 KOSDAQ

Cell therapy biotech developing CAR-T treatments for cancer.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet recruiting 1

Engineered immune cells take aim at Tough-to-Treat blood cancers

Disease control Recruiting now

This trial investigates CRC01, a therapy made from a patient's own immune cells that are genetically modified to recognize and attack cancer cells. It is for adults with large B-cell lymphoma or B-cell acute lymphoblastic leukemia that has returned or not responded to previous tr…

Phase: PHASE1, PHASE2 • Sponsor: Curocell Inc. • Aim: Disease control

Last updated Jul 03, 2026 00:00 UTC